Anaptysbio (ANAB) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Anaptysbio (ANAB) over the last 12 years, with Q3 2025 value amounting to $428000.0.
- Anaptysbio's Accumulated Depreciation & Amortization fell 715.84% to $428000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $428000.0, marking a year-over-year decrease of 715.84%. This contributed to the annual value of $606000.0 for FY2024, which is 705.52% down from last year.
- Anaptysbio's Accumulated Depreciation & Amortization amounted to $428000.0 in Q3 2025, which was down 715.84% from $288000.0 recorded in Q2 2025.
- In the past 5 years, Anaptysbio's Accumulated Depreciation & Amortization ranged from a high of $675000.0 in Q4 2022 and a low of $125000.0 during Q1 2021
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $329000.0 (2023), whereas its average is $377842.1.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first plummeted by 1071.43% in 2021, then skyrocketed by 2960.0% in 2022.
- Anaptysbio's Accumulated Depreciation & Amortization (Quarter) stood at $619000.0 in 2021, then increased by 9.05% to $675000.0 in 2022, then dropped by 3.41% to $652000.0 in 2023, then fell by 7.06% to $606000.0 in 2024, then decreased by 29.37% to $428000.0 in 2025.
- Its Accumulated Depreciation & Amortization stands at $428000.0 for Q3 2025, versus $288000.0 for Q2 2025 and $146000.0 for Q1 2025.